Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin in Anorexia Nervosa
NCT04052568Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Aug 2019
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of psilocybin in anorexia nervosa (AN), sponsored by Johns Hopkins University. Primary endpoints: Hospital Anxiety and Depression Scale and Eating Disorder Quality of Life Scale. Started Aug 2019; status: completed.
02
Drugs
psilocybin
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT04052568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04052568.